Dopl raises $6.3M seed to put robotic ultrasounds in rural clinics
What's the deal? Dopl TechnologiesDealroom has a profile for this one. Try Dealroom → has raised $6.3 million in seed funding to develop and commercialise a remotely operated robotic ultrasound system. SpringTide VenturesDealroom has a profile for this one. Try Dealroom → led the round, joined by WRF CapitalDealroom has a profile for this one. Try Dealroom →, Tacoma Venture FundDealroom has a profile for this one. Try Dealroom →, HeartXDealroom has a profile for this one. Try Dealroom →, Transform Health VenturesDealroom has a profile for this one. Try Dealroom →, Precursor VenturesDealroom has a profile for this one. Try Dealroom →, and other early-stage institutional investors. The Bothell, Washington startup has now raised more than $8 million.
What's the endgame? Dopl pairs off-the-shelf ultrasound probes with commercially available robots, letting a remote sonographer run an exam with haptic feedback and a video link to the patient and onsite staff. The aim is to reach underserved rural communities "to improve access to care and the time it takes for patients to get that care," said chief executive officer Ryan James.
Why now? Dopl is pursuing US Food and Drug Administration clearance and plans to submit its application next year, with the new money funding hires to navigate that process. It currently offers in-person ultrasounds through traveling sonographer services; clearance would let it run remote robotic exams and scale.
What's the runway? The company holds a letter of intent with a rural health care collaborative of 31 critical access hospitals in Washington and has partnerships across the country. It also expects to tap the Rural Health Transformation Program, a $50 billion federal effort distributing funds nationwide from fiscal years 2026 to 2030.
What could go wrong? The market already has competitors, including traditional ultrasound firms and startups. France's AdEchoTechDealroom has a profile for this one. Try Dealroom →, founded in 2008, has secured FDA clearance to sell in the US — a milestone Dopl has yet to reach. James argues Dopl's haptics set it apart, letting remote technicians "actually feel the patient as they're scanning."
The signal: At $6.3 million, Dopl's round sits in the 92nd percentile of US health seed deals — a sign of investor appetite for remote care delivery. As James put it, the approach "represents the next wave of care delivery and shift in mindset in terms of how clinicians operate."
Read more: GeekWire
Image credit: Dopl Technologies
